Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for Ovarian Endometriosis
Mayuko Murakami(Nagoya University), Hiroaki Kajiyama(Keio University)
Cited by 2
Related Papers
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
|Scientific Reports|2017|139
Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway
|Scientific Reports|2020|60
Identifying high-grade serous ovarian carcinoma–specific extracellular vesicles by polyketone-coated nanowires
|Science Advances|2023|53
Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance
|Oncogene|2021|47
Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis
|Reproductive Biology and Endocrinology|2022|47